At present, most chemotherapy drug treatments against cancer are delivered by an intravenous drip over several hours on a hospital ward. Patients normally have to make daily trips for a week at a ...

Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

The therapy also reduced the amount of time patients spend receiving chemotherapy treatment by 49.7% compared with IV Keytruda. At the same time, secondary objectives comparing objective response rate ...

intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. This is a deadly disease with very ...

Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.